Endpoints at #ASCO26

11:00 AM - 11:25 AM ET

In conversation with Jeff Legos

We’ll sit down with Pfizer’s Chief Oncology Officer for an update after his first year on the job, and how he’s thinking through the pharma’s cancer pipeline.

Jeff Legos

Chief Oncology Officer

Pfizer

11:30 AM - 11:55 AM ET

Catching KRAS

For decades, KRAS was an obvious target for cancer treatments. And for decades, it seemed like an undruggable target. But that started to change with the first approved KRAS therapies. Research took off, and now, new data on pancreatic cancer suggest a potential breakthrough. Join pioneers in the space for a conversation on recent progress and where the work goes next.

Kevan Shokat

Professor

UCSF/HHMI

12:00 PM - 12:30 PM ET

Delivering excellence, close to home

Community oncology is the backbone of cancer care in the U.S., treating the majority of patients and ensuring care is delivered close to home in communities across the country. This panel will explore how community oncologists are navigating increasing clinical complexity while continuing to deliver high-quality, patient-centered care. The session will highlight what is working today — and what needs to evolve — to support and strengthen community oncology as a foundational component of the cancer care ecosystem.